CSL Behring Medical Expert Portal is a European webpage designed for healthcare professionals (HCPs) who are interested in serious and life-threatening conditions. Register and login to access the information on this webpage and to receive updates when new content becomes available. If you are interested in the relevant content for a specific country, please refer to the CSL Behring affiliate in your country to obtain relevant information. The medical and scientific information provided on this website is for informational purposes only and should not replace professional advice from a healthcare provider in your area. It is important that you always adhere to the regulations and guidelines relevant to your country.

Disclaimer: Due to compliance regulations, not all content of this webpage is intended for UK healthcare practitioners. If you would like to access UK specific materials on this site, please reach out to your local CSL Behring medical representative (medinfo@cslbehring.com) for assistance.

Disclaimer

CSL EXPERT HIVE

Symposia replays

Evolving evidence for long-term, prophylactic treatment of HAE patients with subcutaneous C1-INH

Pathology:

Hereditary Angioedema

EAACI 2021 symposium

01 – 03 July, Krakow, Poland

Chair: Prof Marcus Maurer

The European Academy of Allergy and Clinical Immunology (EAACI) hosts the world’s largest annual congress specialising in the field of allergy and clinical immunology, which takes place at various cities across the world.

CSL Behring held symposia at the annual EAACI Congress in 2021 and 2022. The discussions focussed on new HAE treatments and the evolution of the HAE management guidelines and treatment goals, with particular focus on how the use of subcutaneous C1 inhibitor for long-term prophylaxis can contribute towards achieving disease control and normalising patients’ lives.